Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00077324 · ClinicalTrials.gov registry record

Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions

A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.

Completed
Registry status
1,000
Enrollment target

NCT00077324: Completed study, sponsored by Alliance for Clinical Trials in Oncology.

NCT00077324 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00077324 has completed, sponsored by Alliance for Clinical Trials in Oncology.

COMPLETED
Registry status
1,000 participants
Enrollment target

Study Summary

RATIONALE: Evaluating specific proteins in the blood may be an effective and noninvasive procedure to help doctors determine if a patient has early non-small cell lung cancer. PURPOSE: This clinical trial is studying proteomic profiling to see how well it works in diagnosing non-small cell lung cancer in patients who are undergoing resection for suspicious (abnormal) stage I lung lesions.

Interventions

  • PROCEDURE biopsy
  • PROCEDURE surgery
  • GENETIC proteomic profiling
  • OTHER surface-enhanced laser desorption/ionization-time of flight mass spectrometry

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2004-02
Est. Completion 2011-11

What the finished NCT00077324 record still lists

NCT00077324 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 4 interventions - of which biopsy is the first listed.

NCT00077324 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00077324 about?

NCT00077324 is a clinical study titled "Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions". RATIONALE: Evaluating specific proteins in the blood may be an effective and noninvasive procedure to help doctors determine if a patient has early non-small cell lung cancer. PURPOSE: This clinical trial is studying proteomic profiling to see how well it works in diagnosing non-small cell lung can...

What is the current status of trial NCT00077324?

This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2004-02. Estimated completion is 2011-11.

What interventions are being tested in trial NCT00077324?

The interventions under investigation include: biopsy (PROCEDURE), surgery (PROCEDURE), proteomic profiling (GENETIC), surface-enhanced laser desorption/ionization-time of flight mass spectrometry (OTHER).

Who is sponsoring clinical trial NCT00077324?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00077324, the US trial registry maintained by the National Library of Medicine. NCT00077324 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.